ApoB is a large glycoprotein with an apparent molecular mass of 550 kDa on NaDodSO4/PAGE. It is a major constituent of most lipoproteins and plays an important role in their metabolism. Recently, apoB cDNA clones have been isolated from an expression library made with mRNA from a human hepatoma cell line. These clones, which were all 1.5-1.6 kilobases (kb) long and corresponded to the 3' end of apoB mRNA, were used to demonstrate that hepatic apoB mRNA is :22 kb long. In the current report, a probe derived from one of these cDNA clones, pB8, was used for in situ hybridization experiments to map the human gene for apoB, APOB, to the distal half of the short arm of chromosome 2. This probe was also used to analyze somatic cell hybrids and, in agreement with the in situ hybridization studies, concordancy was demonstrated with chromosome 2. In addition, two hybrids with chromosome 2 translocations that contain only the short arm reacted with the pB8 probe. A third hybrid with a complex rearrangement of chromosome 2, which deleted an interstitial region and the tip of the short arm of chromosome 2, did not react. These data indicate that APOB maps to either 2p2l-p23 or 2p24-pter. In further studies, DNA from normal individuals, digested with the restriction endonuclease EcoRI and subjected to Southern blot analysis with the pB8 probe, revealed a two-allele restriction fragment length polymorphism (RFLP). The major allele was 11 kb, and the minor allele was 13 kb. The minor allele was present with a frequency of 20-25%. The inheritance of the two alleles was studied in an informative family, and they segregated in a typical autosomal Mendelian fashion. The mapping studies provide the means for understanding the relationship of the APOB locus to others in the human genome, whereas the demonstration of an APOB RFLP increases our ability to assess the role of this locus in determining plasma lipoprotein levels.
Epidemiological studies indicate that the levels of various plasma lipoproteins predict the incidence of myocardial infarction in a population (1) . In these studies, low density lipoprotein (LDL) levels have been positively correlated with coronary heart disease susceptibility (1, 2) . LDL is a particle containing 75% lipid and 25% protein (3) . Most of the protein appears to be a single large polypeptide with a molecular mass of 550 kDa on NaDodSO4/PAGE called apoB. LDL apoB, designated B-100, is thought to be made in liver (4, 5) . An antigenically related apolipoprotein, designated B-48, has a mass of 275 kDa on NaDodSO4/PAGE and is thought to be made in intestine (4, 5) . B-48 is usually present in plasma at much lower concentrations than is B-100. The exact relationship between these two proteins has not been determined.
Genetic variation in apoB may play a role in atherosclerosis susceptibility. In this regard, very little information is available by using protein chemistry techniques. This appears to be the result of technical difficulties arising from the fact that apoB is quite insoluble and easily oxidized after delipidation of LDL (6) . Recently, we have isolated apoB cDNA clones from an expression library made with mRNA from a human hepatoma cell line (7) . The cDNA inserts are 1.5-1.6 kilobases (kb) long and, when used in blot-hybridization analysis, reveal that HepG2 cell apoB mRNA is 22 kb long. The cDNA clones correspond to the 3' end of liverderived apoB mRNA and, therefore, the 3' end of the gene that specifies this mRNA. These cDNA clones can now be used to study apoB genetic variation.
In the current report, a probe was made from one of these cDNA clones and was used to map the human gene for apoB, APOB, both by the in situ and somatic cell hybridization techniques. In addition, the probe was used to demonstrate a restriction fragment length polymorphism (RFLP) associated with the gene that should be useful in assessing the contribution of this locus to atherosclerosis susceptibility.
METHODS
Probe Preparation. In all but the in situ hybridization studies, the apoB probe was prepared as follows. Plasmid DNA from the apoB cDNA clone pB8 was cleaved with the restriction enzymes EcoRI and Pst I to release the cDNA insert. This insert was then isolated from low-melt agarose gels and nick-translated for use as a probe in Southern blotting analyses (7). Whole plasmid DNA was used as a probe in the in situ hybridization experiments as described below.
In Situ Hybridization. Metaphase chromosome preparations were made from normal female leukocytes in short-term culture (8) . Slides either were treated briefly with 0.1% Lipsol and stained with Giemsa or were stained with quinacrine-HCL. After photography, the slides were passed through xylene, destained in fixative, dehydrated by passing them through an alcohol series, dried, and stored under vacuum at room temperature.
To prepare the probe for in situ hybridization, 600 ng of pB8 plasmid DNA was nick-translated with [3H]dATP, [3H]dTTP, and [3H]dCTP (Amersham) in the presence of cold dGTP. The labeled probe had a specific activity of about 1.4 x 107 cpm/,g. Hybridization of the metaphase chromosome preparation to the 3H-labeled probe was carried out in buffer at 37°C for 17 hr (9) . The slides were then washed, coated with Abbreviations: apoA-I, apoB, apoC-I, etc., apolipoproteins A-I, B, C-I, etc.; kb, kilobases; RFLP, restriction fragment length polymorphism; LDL, low density lipoprotein(s); HDL, high density lipoprotein(s).
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Ilford K2 emulsion, and stored at 40C. Lipsol-treated slides were developed after 18 days and restained with Giemsa, and the location of individual grains was recorded by using prints of previously photographed cells.. The quinacrine-HClstained slides were developed after 40 days, and clusters of grains were scored in a similar manner.
Southern Blot Analysis. DNAs digested with EcoRI were electrophoresed on 0.7% agarose gels, stained with ethidium bromide, and UV-irradiated for 1-2 min. The gels were then denatured with 0.5 M NaOH/0.5 M NaCl for 1 hr and neutralized with 1 M Tris'HCl, pH 7.5/1.5 M NaCl for 1 hr at room temperature. DNAs were then blotted onto nitrocellulose filters (10) . The filters were hybridized with 32p_ labeled pB8 cDNA probe at 650C in a buffer containing 0.15 M sodium citrate, 1.5 M NaCl, 0.2% Ficoll, 0.2% polyvinylpyrrolidone, 0.2% bovine serum albumin, and salmon sperm DNA (50 pg/ml). After washing with 15 mM NaCl/1.5 mM sodium citrate/0.1% NaDodSO4 at 650C for 15 min, the filters were exposed to x-ray film.
Somatic Cell Hybrids. The human-rodent somatic cell hybrids were derived from fusion of hypoxanthine phosphoribosyltransferase-deficient mouse RAG cells or Chinese hamster E36, Wg3h, or YH21 cells with leukocytes or fibroblasts from one of five unrelated individuals. Two of the leukocyte donors were female carriers of different reciprocal X/19 translocation chromosomes. These included the X/19W translocation t(X;19)(q23-q25: :ql3) (11) and the X/19B translocation t(X;19)(ql3::pl3) (12) . One ofthe fibroblast donors was afemale carrier of the reciprocal X/13 translocation t(X;13)(q21-q23::q21-q31) (11) . The hybrid cell lines have been characterized for human chromosome complements by isozyme and cytogenetic techniques (13, 14) and with cloned DNA probes for each of the human autosomes and the X chromosome (15, 16) . DNAs prepared from somatic cell hybrids were digested with EcoRI, electrophoresed on 0.7% agarose gels, and subjected to Southern blot analysis.
RFLP Analysis. Human chromosomal DNAs from normal individuals were isolated from peripheral blood lymphocytes or lymphoblast cell lines (17) for RFLP analysis. Lymphoblast cell lines of a Utah family (Utah pedigree K-1340) were obtained from National Institute ofGeneral Medical Sciences Human Genetic Mutant Cell Repository (Camden, NJ). DNAs were digested with EcoRI, electrophoresed on 0.7% agarose gels, and subjected to Southern blot analysis.
RESULTS
In Situ Hybridization. Human metaphase chromosomes from female leukocytes were banded by staining with either Lipsol/Giemsa (Fig. la) or quinacrine HCl (Fig. ic) and were hybridized to the 3H-labeled plasmid from the pB8 cDNA clone. The Lipsol/Giemsa-treated metaphase chromosome preparations were exposed to the probe for 18 days prior to development, and single grains were visualized. In Fig. lb , the single metaphase shown has single grains over each ofthe 2p2 regions. In all, a total of 155 grains in 21 cells were scored, and 10% were located over the short arm of chromosome 2 (2p), with 6.5% on the distal half (histogram not shown). The quinacrine HCl-treated metaphase chromosome preparations were exposed to the probe for 40 days prior to development. In this case, because of the longer exposure, it was necessary to score grain clusters. In Chromosome Mapping Utilizing Somatic Ceil Hybridization. The apoB probe was used in Southern blotting experiments with a mapping panel of DNAs from human-rodent somatic cell hybrid DNAs that had been digested with EcoRI (Fig. 3) . Under these conditions, the apoB probe hybridized to either 11-or 13-kb fragments of human DNA but not at all to rodent DNA. Several of the hybrid DNAs reacted with the apoB probe, and the segregation pattern was concordant with that of chromosome 2p ( Fig. 3 and Table 1 ). Because of translocations, two ofthe somatic cell hybrids contained only the short arm of chromosome 2 (18) , and both reacted with the apoB probe (Fig. 3, lanes 15 and 18) 4-19) , and human-mouse hybrid clones (lanes [20] [21] [22] [23] [24] [25] [26] [27] [28] . DNAs were digested with EcoRI, Southern-blotted, hybridized to 32P-labeled apoB probe, and exposed to x-ray film for 9 days. Human sequences that hybridized to the probe are indicated by arrows. In this DNA mapping panel, the 11-or 13-kb human apoB sequence segregated with chromosome 2p as indicated at the top of the panel. The molecular weight marker is indicated in kb. The black marks below the chromosome segregation data indicate the gel lanes.
deletions, did not react with the apoB probe (Fig. 3, lane 9) . The latter hybrid retained the MDHI (human molate dehydrogenase gene), NMYC (human N-myc gene), and IGK (human immunoglobulin kappa gene) regions (19) . The somatic cell hybrid studies indicate that APOB is either between the IGK locus at 2p12 and the MDHI locus at 2p23 or distal to the MDHI and NMYC loci (Fig. 4) . Taken together, the data from both the in situ and somatic cell hybridization studies are consistent and suggest that APOB is at 2p21-p23 or 2p24-pter (Fig. 4) .
Demonstration of an APOB RFLP with the Enzyme EcoRI. DNAs were isolated from peripheral leukocytes of 16 normal individuals, digested with EcoRI, Southern blotted, and hybridized with the apoB probe. Each DNA specimen showed a simple pattern with either a band of 11 kb or a band of 13 kb, or with both 11-and 13-kb bands (Fig. 5) . The most logical explanation for this was that APOB is a single-copy gene and that EcoRI digestion reveals a two-allele RFLP in normal individuals. The minor allele corresponds to the 13-kb band and is present with a frequency of approximately 20-25%. To demonstrate that this RFLP was inherited, DNA was isolated from lymphocyte cultures derived from members of a three-generation family (Fig. 6) . After EcoRI digestion, the DNA was subjected to Southern blot analysis with the apoB probe. The minor allele ofthe mother (II-1) was contributed by the grandmother (I-1). In the third generation, four of the offspring are heterozygotes for the minor allele (111-2, -3, -4, and -5). This demonstrates inheritance in a Mendelian fashion of these two alleles.
DISCUSSION
In this report, we used an apo B probe that corresponds to the 3' portion of apoB liver mRNA. Southern blotting analysis with this probe reveals a simple pattern explainable by a single-copy APOB gene in the human genome that specifies liver-derived apoB. Through the techniques of in situ and somatic cell hybridization, we have localized this gene to the distal half of the short arm of human chromosome 2. Further studies revealed a two-allele EcoRI RFLP that is inherited in an autosomal Mendelian fashion. The genomic fragment reacting with the probe is either 11 or 13 kb. The 13-kb allele is the minor one with a frequency of 20-25%.
ApoB is one of many apoproteins that exist in lipoprotein particles. In the last few years, cDNA and/or genomic clones have been reported for seven apolipoproteins, A-I, A-II, A-IV, C-I, C-II, C-Ill, and E (20) . Where it has been determined, the genes involved appear to be single copy in the human genome. In addition, based on the existence of gene clusters and structural similarities between the genes, it appears that these seven genes are part of a multigene family. Two clusters have been demonstrated by somatic cell hybridization studies and linkage analysis. The genes for apoA-I, apoC-III, and apoA-IV are on the long arm of chromosome 11 (21) (22) (23) (24) (25) (26) (27) . The genes for apoE, apoC-I, and apoC-II are in the centromeric region of chromosome 19 (28) (29) (30) (31) . By direct cloning ofgenomic DNA and subjecting the cloned fragments to mapping and DNA sequence analysis, it has been determined that the genes for apoA-I and apoC-III are within 2.5 Table 1 . Hybridization pattern of pB8 with DNAs from human-rodent somatic cell hybrids Hy-ChroHuman chromosomes bridi-mozation some 1 2p 2q 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 tThe X column represents the intact X chromosome and the two different derX translocation chromosomes. tFor calculation of the discordant fractions, hybrids with a rearranged chromosome or in which the chromosome was present in less than 15% of cells were excluded. For the X chromosome discordant fraction, only hybrids with an intact X or both the derl9 and derX translocation chromosomes were included. i. 14 showed the hybridization of pB8 probe to the distal half of 2p. In somatic cell hybrid DNA panels, two hybrids that have translocated chromosome 2p showed hybridization with the probe. The third hybrid has a complex rearrangement of chromosome 2p with both a terminal and interstitial deletion of the chromosome arm. The hybrid retains the MDHI and IGK regions. The apoB probe showed no hybridization with this hybrid. The combined data from both in situ hybridization and somatic cell hybrid DNA mapping localize the APOB gene to either 2p21-2p23 or 2p24-2pter.
kb of each other and in opposite orientations (32) . In similar studies, the genes for apoE and apoC-I were shown to be within 4 kb of each other and in the same orientation (33) . The gene for apoA-II resides on the long arm of chromosome 1, apparently unassociated with the other apolipoprotein genes. Studies of apolipoproten gene structure accomplished thus far for APOAJ, APOA2, APOC3, and APOE indicate that they are composed of four exons and three introns, with the introns in strikingly similar locations (20, 34) . Other similarities between the characterized apoprotein genes include extensive DNA homology in the 5' coding region of APOAJ and APOC3 and the existence of multiple 66-base pairs intragenic duplications in the 3' coding region of APOA1, APOA4, and APOE (17, 20, 33, 34) . The location ofAPOB to a region ofthe genome quite separate from the genes for other apolipoproteins suggests that it may not be part of this gene family. Further work on the structure of the APOB gene will be necessary to establish this conclusion.
In this report, we demonstrate the existence of an APOB EcoRI RFLP. This RFLP should be useful in genetic studies to determine the contribution of APOB locus to phenotypes characterized by dyslipoproteinemia and/or atherosclerosis susceptibility. In family studies, where the kindred is informative for this RFLP, cosegregation of a phenotype with an APOB allele might be demonstrated. This would imply that the APOB locus plays a role in the pathogenesis of the Southern blot analysis. The filter was hybridized to the 32P-labeled apoB probe and exposed to x-ray film for three days. The molecular weight marker is indicated in kb. Two EcoRI fragments, 11 and 13 kb, hybridized to the probe. condition under study. For example, three disorders have been described involving failure to synthesize hepatic apoB, abetalipoproteinemia (3) , homozygous hypobetalipoproteinemia (3) , and normotriglyceridemic abetalipoproteinemia (35) . Utilizing APOB RFLPs, it would be possible to study the families of such patients to determine whether the primary genetic lesion was associated with the APOB locus.
In addition to family studies, the EcoRI APOB RFLP may itself be associated with dyslipoproteinemia. RFLPs have been reported for some ofthe other apolipoprotein genes, and some of these have been associated with lipoprotein abnormalities. Several RFLPs have been identified in association with the gene APOAJ by using the enzymes Sst I (Sac I), Pst I, and Xmn I (36) (37) (38) . The minor allele frequency in each situation is 10-15%. In three different studies, the Sst I minor allele has been associated with high triglyceride levels (36) and low high density lipoprotein (HDL) levels (37) and has not been associated with lipoprotein abnormalities (38) . The Sst I polymorphism associated with APOAJ was shown to be due to a DNA base substitution downstream from APOAJ, which actually resides in the 3' untranslated region ofAPOC3 (25) . This is not associated with any qualitative abnormality in the coding region of APOC3 (39); however, it raises the interesting question as to whetherAPOC3 abnormalities may have some association with altered triglyceride and/or HDL levels. In a recent study, the Xmn I RFLP has been found more frequently in type Ub, III, and V, but not type IV hyperlipidemia (38) . There is also an RFLP in an Alu sequence 3' to APOA2 r4yealed with the enzyme Msp 1 (36) .
The minor allele frequency is 15-20%, and homozygosity for this allele is associated with altered HDL composition and an increase in serum apoA-II levels. Finally, in association with APOC2, there are both Taq I and Bgi I polymorphisms with minor allele frequencies of 40-45% (25, 40) . There is no obvious association with dyslipoproteinemia; however, linkage disequilibrium exists between both of these RFLPs and between the Taq I RFLP and the e2 APOE allele.
Since the apoB probe corresponds to the 3' end of hepatic apoB mRNA, the EcoRI APOB RFLP is presumably at the 3' end of the gene. It is uncertain as yet whether the site of the DNA variation is within the gene or 3' to it. To define this, additional genomic restriction mapping and perhaps isolation of other probes will be necessary. This APOB EcoRI RFLP Biochemistry: Huang et aL Proc. Natl. Acad. Sci. USA 83 (1986) shows genetic variation of the APOB gene demonstrated at the DNA level, which has not been reported before. HoweVer, genetically determined variation in apoB has been demonstrated using immunological techniques. Antisera from multiply transfused patients have been used to define two series of allelic variants called Lp and Ag. The presence of both of these antigens appears to be associated with marginally increased plasma cholesterol levels and risk of atherosclerosis (see ref. 41 for a recent review). In another more recent study, individuals have been identified with reduced binding to anti-apoB monoclonal antibodies (42) . Three phenotypes of strong, weak, and intermediate binding were identified, and family studies suggested a genetic basis consistent with a single genetic locus, with two alleles specifying strong and weak binding forms of apoB. Thus, the intermediate binding pattern is the result of heterozygosity for the strong and weak binding alleles, whereas the other two patterns represent homozygosity for their respective alleles.
In a study of phenotype frequencies in a small number of unrelated individuals, minor allele frequency (weak binding) was found to be 301% (42) . The effect of this apoB genetic variation on plasma lipoprotein levels has yet to be determined.
In conclusion, these studies provide a basis for understanding the role of the APOB locus in human atherosclerosis susceptibility.
Papers describing the cloning of rat (43) and human (44) apoB cDNA have been published recently. As in our own work (7), both reports found apoB mRNA to be ;20 kb in length. The paper about human apoB cDNA reports 595 base pairs of DNA sequence that represents an internal segment of apoB mRNA without untranslated flanking sequence or 3'
terminal poly(dA). Preliminary sequence analysis of 500 base pairs of the cDNA probe used in the current experiments reveals it to begin at the poly(A) site, but it does not overlap the sequences reported by the other investigators. This is not surprising in view of the length of apoB mRNA.
